Literature DB >> 32343942

Association of miRNA-145 with the occurrence and prognosis of hydrosalpinx-induced defective endometrial receptivity.

Qingli Wang1, Haiquan Ai1, Xia Li1, Haiqing Tian1, Bingxue Ning1, Meng Zhang1, Xiaolin La1.   

Abstract

MiR-145 is reported to facilitate inflammation and is also associated with unsuccessful embryonic implantation. Whether miR-145 mediates inflammatory response underlying hydrosalpinx-induced defective endometrial receptivity (ER) remains unclear, and this study attempted to clarify this point. Endometrium samples were collected from hydrosalpinx patients (case, n = 243) and patients with tubal patency/obstruction (control, n = 187). The peripheral blood samples of cases and controls were collected to determine the genotypes of miR-145 SNPs. The value of miR-145 expression in the diagnosis and prognostic estimation of hydrosalpinx was assessed using ROC curve and regression analysis, respectively. Lipopolysaccharide (LPS) cell model was established with endometrial cells, and cells were transfected with miR-145 mimic, inhibitor, or negative control. MiR-145 and cytokine levels were quantified by quantitative reverse transcription PCR or western blot. MiR-145 expression was significantly higher in hydrosalpinx compared to control group, and high miR-145 expression was significantly associated with moderate/severe tube lesion, high pulsatility index (>1.06), and high resistance index (>0.61) in hydrosalpinx patients. ROC curve analysis indicated that monitoring miR-145 expression may be useful for the diagnosis of hydrosalpinx (AUC = 0.704). A alleles of rs41291957 (G>A) and rs353292 (G>A) were significantly associated with an increased risk of hydrosalpinx compared to G allele (p < 0.05), yet the mutant allele of rs353291 (A>G) and rs4705343 (T>C) significantly reduced susceptibility to hydrosalpinx compared to the wild type allele. Treatments with miR-145 mimic and LPS in endometrial cells significantly increased the levels of transforming growth factor-β1, tumor necrosis factor -α, interleukin (IL)-6, and IL-8 compared to negative control, while treatment with miR-145 inhibitor decreased the cytokine levels. In conclusion, abnormally expressed miR-145 may be involved in hydrosalpinx-induced ER defects by regulating the inflammatory response.

Entities:  

Year:  2021        PMID: 32343942      PMCID: PMC7861628          DOI: 10.17305/bjbms.2020.4538

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  40 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Effect of hydrosalpinx fluid on secretion of trophoblastic matrix metalloproteinases.

Authors:  Nicole Jastrow; Didier Chardonnens; Melvina Araman; Arielle Meisser; Aldo Campana; Paul Bischof
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

3.  Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies.

Authors:  E Camus; C Poncelet; F Goffinet; B Wainer; F Merlet; I Nisand; H J Philippe
Journal:  Hum Reprod       Date:  1999-05       Impact factor: 6.918

4.  MicroRNA-145 influences the balance of Th1/Th2 via regulating RUNX3 in asthma patients.

Authors:  Linxia Fan; Xiaojun Wang; Linlan Fan; Qizhang Chen; Hong Zhang; Hui Pan; Aixia Xu; Hongjuan Wang; Yang Yu
Journal:  Exp Lung Res       Date:  2016-11-30       Impact factor: 2.459

5.  The differential expression of microRNAs between implantation sites and interimplantation sites in early pregnancy in mice and their potential functions.

Authors:  Yanqing Geng; Junlin He; Yubin Ding; Xuemei Chen; Yongjiang Zhou; Shangjing Liu; Xueqing Liu; Yingxiong Wang
Journal:  Reprod Sci       Date:  2014-03-06       Impact factor: 3.060

6.  The low expression of leukemia inhibitory factor in endometrium: possible relevant to unexplained infertility with multiple implantation failures.

Authors:  Man Wu; Yongixang Yin; Min Zhao; Lingqing Hu; Qi Chen
Journal:  Cytokine       Date:  2013-03-29       Impact factor: 3.861

7.  STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.

Authors:  Dimitrios Iliopoulos; Savina A Jaeger; Heather A Hirsch; Martha L Bulyk; Kevin Struhl
Journal:  Mol Cell       Date:  2010-08-27       Impact factor: 17.970

8.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

Authors:  Dennis Löffler; Katja Brocke-Heidrich; Gabriele Pfeifer; Claudia Stocsits; Jörg Hackermüller; Antje K Kretzschmar; Renate Burger; Martin Gramatzki; Conny Blumert; Kay Bauer; Helena Cvijic; A Kerstin Ullmann; Peter F Stadler; Friedemann Horn
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

9.  Let-7-mediated suppression of mucin 1 expression in the mouse uterus during embryo implantation.

Authors:  Wilasinee Inyawilert; Tzu-Yen Fu; Chun-Ting Lin; Pin-Chi Tang
Journal:  J Reprod Dev       Date:  2015-01-26       Impact factor: 2.214

10.  Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.

Authors:  Xuetian Yue; Yuhan Zhao; Cen Zhang; Jun Li; Zhen Liu; Juan Liu; Wenwei Hu
Journal:  Oncotarget       Date:  2016-01-26
View more
  3 in total

1.  Association of miRNA-145 Single Nucleotide Polymorphisms in Abdominal Aortic Aneurysms.

Authors:  Natasha Hasemaki; Nikolaos-Panagiotis Andreou; Evangelia Legaki; Athanasios Katsargyris; Maria Gazouli; Christos Klonaris
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

2.  MicroRNA Variants miR-27a rs895819 and miR-423 rs6505162, but not miR-124-1 rs531564, are Linked to Endometriosis and its Severity.

Authors:  S O Jaafar; J O Jaffar; S A Ibrahim; K K Jarjees
Journal:  Br J Biomed Sci       Date:  2022-01-07       Impact factor: 2.432

3.  A comprehensive analysis of miRNA/isomiRs profile of hydrosalpinx patients with interventional ultrasound sclerotherapy.

Authors:  Zhengyi Cao; Bo Xu; Yan Wu; Kang Luan; Xin Du
Journal:  PLoS One       Date:  2022-08-15       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.